Liver support systems today;A májpótló kezelés mai leheto″sé gei

Orvosi Hetilap

Volumn 150, Issue 51, 2009, Pages 2299-2307

  Rikker, Csaba ^a  

^a Peterfy Sandor Utcai Korhaz   (Hungary)

Author keywords

Albumin dialysis; Albumin bound toxins; Fractionated plasma separation and adsorption; Liver failure; Liver support

Indexed keywords

ADSORBENT; BLOOD CLOTTING FACTOR; PLASMA PROTEIN; TOXIN; WATER;

ADSORPTION; ALBUMIN DIALYSIS; BIOARTIFICIAL LIVER; BIOREACTOR; CHRONIC LIVER DISEASE; CROSS CIRCULATION; CROSS HEMODIALYSIS; DECOMPENSATED LIVER CIRRHOSIS; DIALYSIS; DONOR; EXCHANGE BLOOD TRANSFUSION; FINANCIAL MANAGEMENT; FRACTIONATED PLASMA SEPARATION AND ADSORPTION SYSTEM; HEMODIABSORPTION; HEMODIALYSIS; HEMOPERFUSION; HEPATOMA CELL; HOLLOW FIBER; HUMAN; IMMUNOLOGY; LIVER CELL; LIVER DIALYSIS UNIT; LIVER FAILURE; LIVER FUNCTION; LIVER PERFUSION; LIVER STRUCTURE; LIVER SUPPORT; LIVER TRANSPLANTATION; MORTALITY; PLASMAPHERESIS; REVIEW; SEPARATION TECHNIQUE; SINGLE PASS ALBUMIN DIALYSIS; SURVIVAL; SWINE; UNITED STATES;

ALBUMINS; EXTRACORPOREAL CIRCULATION; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; PLASMAPHERESIS; RENAL DIALYSIS; SORPTION DETOXIFICATION;

EID: 73849100390     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28769     Document Type: Review

References (50)

1. Millis, J. M., Losanoff, J. E.: Technology insight: liver support systems. Nat. Clin. Pract. Gastroenterol. Hepatol., 2005, 2, 398-405.
2. Kramer, L.: Acut liver failure. Wien. Klin. Wochenschr., 2004, 116, 68-71.
3. Polson, J., Lee, W. M.: AASLD position paper: The management of acute liver failure. Hepatology, 2005, 41, 1179-1197.
4. Kiley, J. E., Pender, J. C., Welch, H. F. es mtsa: Ammonia intoxication treated by hemodialysis. N. Engl. J. Med., 1958, 259, 1156-1161.
5. Schechter, D. C., Nealon, T. F. Jr., Gibbon, J. H. Jr.: A simple extracorporeal device for reducing elevated blood ammonia levels; preliminary report. Surgery, 1958, 44, 892-897.
6. Kimoto, S.: The artificial liver: experiments and clinical application. Trans. Am. Soc. Artif. Intern. Organs, 1959, 5, 102-112.
7. Yatzidis, H., Oreoploulos, D., Triataphyllides, D.: Treatment of severe barbiturate poisoning. Lancet, 1965, 2, 216-217.
8. Eiseman, B., Liem, D. S., Raffucci, F.: Heterologous liver perfusion in treatment of hepatic failure. Ann. Surg., 1965, 162, 329-345.
9. Abouna, G. M., Boehmig, H. G., Serrou, B. es mtsai: Long-term hepatic support by intermittent multi-species liver perfusions. Lancet, 1970, 2, 391-396.
10. Burnell, J. M., Dawborn, J. K., Epstein, R. B. es mtsai: Acute hepatic coma treated by cross-circulation or exchange transfusion. N. Engl. J. Med., 1967, 276, 935-943.
11. Sabin, S., Merritt, J. A.: Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange). Ann. Intern. Med., 1968, 68, 1-7.
12. Yamazaki, Z., Kamai, F., Ideduki, Y. es mtsa: Extracorporeal methods of liver failure treatment. Biomater. Artif. Cells. Artif. Organs, 1992, 15, 296-299.
13. Ho, D. W. Y., Fan, S. T., Woo, Y. H. es mtsai: Selective plasma filtration for treatment of fulminant hepatic failure induced by Dgalactosamine in a pig model. Gut, 2002, 50, 869-876.
14. Opolon, P., Rapin, J. R., Huguet, C. es mtsai: Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD). Trans. Am. Soc. Artif. Intern. Organs, 1976, 22, 701-710.
15. Knell, A. J., Dukes, D. C.: Dialysis procedures in acute liver coma. Lancet, 1976, 2, 402-403.
16. Brunner, G., Tegtmeier, F.: Enzymatic detoxification using lipophilic hollow-fiber membranes: I. Glucuronidation reactions. Artif. Organs, 1984, 8, 161-166.
17. Ozawa, K., Kamiyama, Y., Kimura, K. es mtsai: The effects of heterologous liver cross-hemodialysis on adenylate energy charge of the remnant liver after major hepatic resection. Artif. Organs, 1982, 6, 447-452.
18. Yoshiba, M., Yamada, H., Yoshikawa, Y. es mtsai: Hemodiafiltration treatment of deep hepatic coma by protein passing membrane: case report. Artif. Organs, 1986, 10, 417-419.
19. Fox, I. J., Langnas, A. N., Fristoe, L. W. es mtsai: Successful application of extracorporeal liver perfusion: a technology whose time has come. Am. J. Gastroenterol., 1993, 88, 1876-1881.
20. Levy, M. F., Crippin, J., Sutton, S.: Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/ hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation, 2000, 69, 272-280.
21. Filippi, C., Keatch S. A., Rangar D. es mtsai: Improvement of C3A cell metabolism for usage in bioartificial liver support systems. J. Hepatol., 2004, 41, 599-605.
22. Millis, J. M., Cronin, D. C., Johnson, R. es mtsai: Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation, 2002, 74, 1735-1746.
23. George, J.: artificial liver support systems. J. Assoc. Physicians India, 2004, 52, 719-722.
24. Van de Kerkhove, M. P., Di Florio, E., Scuderi, V. es mtsai: Bridging of a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. Cell Transplant., 2003, 12, 563-568.
25. Sauer, I. M., Zeilinger, K., Pless, G. es mtsai: Extracorporeal liver support based on primary human liver cells and albumin dialysis - treatment of a patient with primary graft non-function. J. Hepatol., 2003, 39, 649-653.
26. Wang, L., Sun, J., Li, L. es mtsai: Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell. Transplant., 1998, 7, 459.
27. Ash, S. R.: Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif. Organs, 1994, 18, 355-362.
28. Ash, S. R.: Powdered sorbent liver dialysis and pheresis in treatment of hepatic failure. Ther. Apher., 2001, 5, 404-416.
29. Ash, S. R., Steczko, J., Knab, W. R. es mtsai: Push-pull sorbentbased pheresis and hemodiabsorption in the treatment of hepatic failure: preliminary results of a clinical trial with the BioLogic- DTPF System. Ther. Apher., 2000, 3, 218-228.
30. Constantine, J., Karvellas, N. G., Demetrios, K. es mtsai: Benchto- bedside review: Current evidence for extracorporeal albumin dialysis systems in liver failure. Crit. Care, 2007, 11, 215.
31. Boonsrirat, U., Tiranathanagul, K., Srisawat, N. es mtsai: Effective bilirubin reduction by single-pass albumin dialysis in liver failure. Artif. Organs, 2009, 33, 648-653.
32. Rahman, E., Al Suwaida, A. K., Askar, A.: Single pass albumin dialysis in hepatorenal syndrome. Saudi J. Kidney Dis. Transpl., 2008, 19, 479-484.
33. Churchwell, M. D., Pasko, D. A., Smoyerand, W. E. es mtsa: Enhanced clearance of highly protein-bound drugs by albuminsupplemented dialysate during modeled continuous hemodialysis. Nephrol. Dial. Transplant., 2009, 24, 231-238.
34. Stange, J., Ramlow, W., Mitzner, S. es mtsai: Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif. Organs, 1993, 17, 809-813.
35. Tan, H. K.: Molecular adsorbent recirculating system (MARS). Ann. Acad. Med. Singapore, 2004, 33, 329-335.
36. Sauer, I. M., Goetz, M., Steffen, I. es mtsai: In vitro comparison of the molecular adsorbent recirculation system (MARS) and single- pass albumin dialysis (SPAD). Hepatology, 2004, 39, 1408-1414.
37. Peszynski, P., Klammt, S., Peters, E. es mtsai: Albumin dialysis: single pass vs. recirculation (MARS). Liver, 2002, 22, 40-42.
38. Kortgen, A., Rauchfuss, F., Gotz, M. es mtsai: Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis - a retrospective analysis. Ther. Apher. Dial., 2009, 13, 419-425.
39. Rosa Diez, G., Greloni, G., Gadano, A. es mtsai: Combined single pass albumin extended dialysis (SPAED). Nephrol. Dial. Transplant., 2007, 22, 2731-2732.
40. Falkenhagen, D., Strobl, W., Vogt, G. es mtsai: Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif. Organs, 1999, 23, 81-86.
41. Rifai, K., Ernst, T., Kretschmer, U. es mtsai: Prometheus - a new extracorporeal system for the treatment of liver failure. J. Hepatol., 2003, 39, 984-990.
42. Rifai, K., Ernst, T., Kretschmer, U. es mtsai: The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif., 2005, 23, 298-302.
43. Krisper, P., Stauber, R. E.: Technology Insight: artificial extracorporeal liver support - how does PrometheusR compare with MARSR? Nat. Clin. Pract. Nephrol., 2007, 3, 267-276.
44. Evenepoel, P., Laleman, W., Wilmer, A. es mtsai: Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif. Organs, 2006, 30, 276-284.
45. Laleman, W., Wilmer, A., Evenepoel, P. es mtsai: Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit. Care, 2006, 10, R108.
46. Faenza, S., Baraldi, O., Bernardi, M. es mtsai: Mars and Prometheus: our clinical experience in acute chronic liver failure. Transplant. Proc., 2008, 40, 1169-1171.
47. Kjaergard, L. L., Liu, J., Als-Nielsen, B. es mtsai: artificial and Bioartificial Support Systems for Acute-on-Chronic Liver Failure. A Systematic Review. JAMA, 2003, 289, 217-222.
48. Demetriou, A. A., Brown, R. S. Jr., Busuttil, R.W. es mtsai: Prospective, randomized, multicenter, controlled trial of a bioartifi - cial liver in treating acute liver failure. Ann. Surg., 2004, 239, 660-670.
49. Khuroo, M. S., Khuroo, M. S., Farahat, K. L.: Molecular Adsorbent Recirculating System for Acute and Acute-on-Chronic Liver Failure: A Meta-analysis. Liver Transpl., 2004, 10, 1099-1106.
50. Bakos A., Rikker Cs., Tovarosi Sz. es mtsa: A legujabb extracorporalis eliminacios eljaras (PrometheusR kezeles) terapias hatekonysaga mergezes okozta akut majelegtelensegben. Orv. Hetil., 2007, 148, 1981-1988.